nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrabenazine—CBR1—Doxorubicin—urinary bladder cancer	0.681	0.963	CbGbCtD
Tetrabenazine—CYP2D6—Doxorubicin—urinary bladder cancer	0.0262	0.0371	CbGbCtD
Tetrabenazine—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—urinary bladder cancer	0.0105	0.124	CbGpPWpGaD
Tetrabenazine—CBR1—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.00714	0.0845	CbGpPWpGaD
Tetrabenazine—SLC18A2—Amine compound SLC transporters—SLC14A2—urinary bladder cancer	0.00607	0.0719	CbGpPWpGaD
Tetrabenazine—CBR1—prostate gland—urinary bladder cancer	0.00569	0.129	CbGeAlD
Tetrabenazine—SLC18A2—prostate gland—urinary bladder cancer	0.00489	0.111	CbGeAlD
Tetrabenazine—CBR1—seminal vesicle—urinary bladder cancer	0.00481	0.109	CbGeAlD
Tetrabenazine—CBR1—Azacitidine—Gemcitabine—urinary bladder cancer	0.0048	1	CbGdCrCtD
Tetrabenazine—CYP2D6—urine—urinary bladder cancer	0.00455	0.103	CbGeAlD
Tetrabenazine—CYP2D6—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.00446	0.0529	CbGpPWpGaD
Tetrabenazine—CBR1—renal system—urinary bladder cancer	0.00388	0.0881	CbGeAlD
Tetrabenazine—CBR1—urethra—urinary bladder cancer	0.00381	0.0866	CbGeAlD
Tetrabenazine—CBR1—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.0038	0.0449	CbGpPWpGaD
Tetrabenazine—SLC18A2—Dopaminergic Neurogenesis—GLI1—urinary bladder cancer	0.00368	0.0436	CbGpPWpGaD
Tetrabenazine—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—urinary bladder cancer	0.00366	0.0433	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—UGT2B7—urinary bladder cancer	0.00336	0.0398	CbGpPWpGaD
Tetrabenazine—CBR1—female reproductive system—urinary bladder cancer	0.0031	0.0706	CbGeAlD
Tetrabenazine—CYP2D6—Miscellaneous substrates—CYP4B1—urinary bladder cancer	0.00291	0.0344	CbGpPWpGaD
Tetrabenazine—CBR1—vagina—urinary bladder cancer	0.00281	0.0638	CbGeAlD
Tetrabenazine—SLC18A2—female reproductive system—urinary bladder cancer	0.00267	0.0607	CbGeAlD
Tetrabenazine—CYP2D6—Fatty acids—CYP4B1—urinary bladder cancer	0.00243	0.0288	CbGpPWpGaD
Tetrabenazine—SLC18A2—vagina—urinary bladder cancer	0.00241	0.0549	CbGeAlD
Tetrabenazine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.00238	0.0281	CbGpPWpGaD
Tetrabenazine—CBR1—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.00225	0.0266	CbGpPWpGaD
Tetrabenazine—CYP2D6—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.00206	0.0244	CbGpPWpGaD
Tetrabenazine—CBR1—lymph node—urinary bladder cancer	0.00182	0.0413	CbGeAlD
Tetrabenazine—CYP2D6—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.00167	0.0198	CbGpPWpGaD
Tetrabenazine—SLC18A2—lymph node—urinary bladder cancer	0.00156	0.0355	CbGeAlD
Tetrabenazine—CBR1—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.00132	0.0157	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—NQO1—urinary bladder cancer	0.0013	0.0154	CbGpPWpGaD
Tetrabenazine—CYP2D6—renal system—urinary bladder cancer	0.00111	0.0253	CbGeAlD
Tetrabenazine—CBR1—NRF2 pathway—GSTP1—urinary bladder cancer	0.00108	0.0128	CbGpPWpGaD
Tetrabenazine—SLC18A2—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00108	0.0128	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00102	0.0121	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—GSTM1—urinary bladder cancer	0.000995	0.0118	CbGpPWpGaD
Tetrabenazine—CYP2D6—female reproductive system—urinary bladder cancer	0.000891	0.0203	CbGeAlD
Tetrabenazine—Urethral disorder—Thiotepa—urinary bladder cancer	0.000833	0.00522	CcSEcCtD
Tetrabenazine—Diarrhoea—Mitomycin—urinary bladder cancer	0.000821	0.00514	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Fluorouracil—urinary bladder cancer	0.000816	0.00511	CcSEcCtD
Tetrabenazine—Blood disorder—Epirubicin—urinary bladder cancer	0.000816	0.00511	CcSEcCtD
Tetrabenazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000802	0.00949	CbGpPWpGaD
Tetrabenazine—Eye disorder—Thiotepa—urinary bladder cancer	0.000794	0.00497	CcSEcCtD
Tetrabenazine—Dizziness—Mitomycin—urinary bladder cancer	0.000794	0.00497	CcSEcCtD
Tetrabenazine—CYP2D6—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000792	0.00937	CbGpPWpGaD
Tetrabenazine—Cardiac disorder—Thiotepa—urinary bladder cancer	0.000789	0.00494	CcSEcCtD
Tetrabenazine—Angiopathy—Thiotepa—urinary bladder cancer	0.000771	0.00483	CcSEcCtD
Tetrabenazine—Dysarthria—Methotrexate—urinary bladder cancer	0.00077	0.00482	CcSEcCtD
Tetrabenazine—Sweating—Gemcitabine—urinary bladder cancer	0.000763	0.00478	CcSEcCtD
Tetrabenazine—Vomiting—Mitomycin—urinary bladder cancer	0.000763	0.00478	CcSEcCtD
Tetrabenazine—Dysphagia—Etoposide—urinary bladder cancer	0.000763	0.00478	CcSEcCtD
Tetrabenazine—Blood disorder—Doxorubicin—urinary bladder cancer	0.000755	0.00473	CcSEcCtD
Tetrabenazine—Headache—Mitomycin—urinary bladder cancer	0.000752	0.00471	CcSEcCtD
Tetrabenazine—Mental disorder—Thiotepa—urinary bladder cancer	0.000744	0.00466	CcSEcCtD
Tetrabenazine—Tension—Thiotepa—urinary bladder cancer	0.000726	0.00455	CcSEcCtD
Tetrabenazine—Dysarthria—Epirubicin—urinary bladder cancer	0.00072	0.00451	CcSEcCtD
Tetrabenazine—Nervousness—Thiotepa—urinary bladder cancer	0.000718	0.0045	CcSEcCtD
Tetrabenazine—Nausea—Mitomycin—urinary bladder cancer	0.000713	0.00447	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Gemcitabine—urinary bladder cancer	0.000706	0.00442	CcSEcCtD
Tetrabenazine—Urethral disorder—Gemcitabine—urinary bladder cancer	0.000701	0.00439	CcSEcCtD
Tetrabenazine—Gait disturbance—Epirubicin—urinary bladder cancer	0.000698	0.00437	CcSEcCtD
Tetrabenazine—Agitation—Thiotepa—urinary bladder cancer	0.00068	0.00426	CcSEcCtD
Tetrabenazine—Bradycardia—Cisplatin—urinary bladder cancer	0.000678	0.00425	CcSEcCtD
Tetrabenazine—Dysarthria—Doxorubicin—urinary bladder cancer	0.000667	0.00417	CcSEcCtD
Tetrabenazine—Cardiac disorder—Gemcitabine—urinary bladder cancer	0.000663	0.00415	CcSEcCtD
Tetrabenazine—Leukopenia—Thiotepa—urinary bladder cancer	0.000662	0.00415	CcSEcCtD
Tetrabenazine—Ecchymosis—Methotrexate—urinary bladder cancer	0.000658	0.00412	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Cisplatin—urinary bladder cancer	0.000658	0.00412	CcSEcCtD
Tetrabenazine—Urethral disorder—Cisplatin—urinary bladder cancer	0.000653	0.00409	CcSEcCtD
Tetrabenazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00065	0.0077	CbGpPWpGaD
Tetrabenazine—Angiopathy—Gemcitabine—urinary bladder cancer	0.000649	0.00406	CcSEcCtD
Tetrabenazine—Gait disturbance—Doxorubicin—urinary bladder cancer	0.000646	0.00404	CcSEcCtD
Tetrabenazine—Anxiety—Thiotepa—urinary bladder cancer	0.000628	0.00393	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.000625	0.00392	CcSEcCtD
Tetrabenazine—Eye disorder—Cisplatin—urinary bladder cancer	0.000623	0.0039	CcSEcCtD
Tetrabenazine—Cardiac disorder—Cisplatin—urinary bladder cancer	0.000618	0.00387	CcSEcCtD
Tetrabenazine—Ecchymosis—Epirubicin—urinary bladder cancer	0.000616	0.00386	CcSEcCtD
Tetrabenazine—Confusional state—Thiotepa—urinary bladder cancer	0.000609	0.00381	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Etoposide—urinary bladder cancer	0.000603	0.00377	CcSEcCtD
Tetrabenazine—Urethral disorder—Etoposide—urinary bladder cancer	0.000598	0.00375	CcSEcCtD
Tetrabenazine—Nervous system disorder—Thiotepa—urinary bladder cancer	0.000592	0.00371	CcSEcCtD
Tetrabenazine—Skin disorder—Thiotepa—urinary bladder cancer	0.000586	0.00367	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—GSTZ1—urinary bladder cancer	0.000582	0.00689	CbGpPWpGaD
Tetrabenazine—Eye disorder—Etoposide—urinary bladder cancer	0.00057	0.00357	CcSEcCtD
Tetrabenazine—Ecchymosis—Doxorubicin—urinary bladder cancer	0.00057	0.00357	CcSEcCtD
Tetrabenazine—Cardiac disorder—Etoposide—urinary bladder cancer	0.000566	0.00355	CcSEcCtD
Tetrabenazine—Leukopenia—Gemcitabine—urinary bladder cancer	0.000557	0.00349	CcSEcCtD
Tetrabenazine—Angiopathy—Etoposide—urinary bladder cancer	0.000554	0.00347	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—NAT1—urinary bladder cancer	0.000552	0.00653	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—GSTO2—urinary bladder cancer	0.000552	0.00653	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000548	0.00649	CbGpPWpGaD
Tetrabenazine—Leukopenia—Fluorouracil—urinary bladder cancer	0.000548	0.00343	CcSEcCtD
Tetrabenazine—Tremor—Cisplatin—urinary bladder cancer	0.000543	0.0034	CcSEcCtD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000543	0.00642	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—KMT2A—urinary bladder cancer	0.00054	0.00639	CbGpPWpGaD
Tetrabenazine—Somnolence—Thiotepa—urinary bladder cancer	0.000537	0.00336	CcSEcCtD
Tetrabenazine—Osteoarthritis—Methotrexate—urinary bladder cancer	0.000528	0.00331	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.000526	0.00329	CcSEcCtD
Tetrabenazine—Decreased appetite—Thiotepa—urinary bladder cancer	0.000525	0.00329	CcSEcCtD
Tetrabenazine—Fatigue—Thiotepa—urinary bladder cancer	0.00052	0.00326	CcSEcCtD
Tetrabenazine—Leukopenia—Cisplatin—urinary bladder cancer	0.000519	0.00325	CcSEcCtD
Tetrabenazine—Constipation—Thiotepa—urinary bladder cancer	0.000516	0.00323	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—UGT2B7—urinary bladder cancer	0.000505	0.00597	CbGpPWpGaD
Tetrabenazine—Irritability—Methotrexate—urinary bladder cancer	0.000504	0.00316	CcSEcCtD
Tetrabenazine—Confusional state—Fluorouracil—urinary bladder cancer	0.000503	0.00315	CcSEcCtD
Tetrabenazine—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000498	0.00312	CcSEcCtD
Tetrabenazine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000497	0.00312	CcSEcCtD
Tetrabenazine—Ataxia—Methotrexate—urinary bladder cancer	0.000497	0.00311	CcSEcCtD
Tetrabenazine—Osteoarthritis—Epirubicin—urinary bladder cancer	0.000495	0.0031	CcSEcCtD
Tetrabenazine—Skin disorder—Gemcitabine—urinary bladder cancer	0.000493	0.00309	CcSEcCtD
Tetrabenazine—Anxiety—Cisplatin—urinary bladder cancer	0.000492	0.00308	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.000491	0.00307	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.00049	0.00307	CcSEcCtD
Tetrabenazine—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00049	0.00307	CcSEcCtD
Tetrabenazine—Breast disorder—Methotrexate—urinary bladder cancer	0.000478	0.00299	CcSEcCtD
Tetrabenazine—Body temperature increased—Thiotepa—urinary bladder cancer	0.000477	0.00299	CcSEcCtD
Tetrabenazine—Leukopenia—Etoposide—urinary bladder cancer	0.000476	0.00298	CcSEcCtD
Tetrabenazine—Hypotension—Gemcitabine—urinary bladder cancer	0.000475	0.00297	CcSEcCtD
Tetrabenazine—Hypotension—Fluorouracil—urinary bladder cancer	0.000467	0.00292	CcSEcCtD
Tetrabenazine—Ataxia—Epirubicin—urinary bladder cancer	0.000465	0.00291	CcSEcCtD
Tetrabenazine—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000464	0.00291	CcSEcCtD
Tetrabenazine—Skin disorder—Cisplatin—urinary bladder cancer	0.00046	0.00288	CcSEcCtD
Tetrabenazine—Insomnia—Gemcitabine—urinary bladder cancer	0.000459	0.00288	CcSEcCtD
Tetrabenazine—Osteoarthritis—Doxorubicin—urinary bladder cancer	0.000458	0.00287	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000458	0.00287	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—CYP4B1—urinary bladder cancer	0.000454	0.00538	CbGpPWpGaD
Tetrabenazine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000453	0.00284	CcSEcCtD
Tetrabenazine—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.000452	0.00283	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.000452	0.00283	CcSEcCtD
Tetrabenazine—Insomnia—Fluorouracil—urinary bladder cancer	0.000452	0.00283	CcSEcCtD
Tetrabenazine—Somnolence—Gemcitabine—urinary bladder cancer	0.000451	0.00283	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000449	0.00281	CcSEcCtD
Tetrabenazine—Breast disorder—Epirubicin—urinary bladder cancer	0.000447	0.0028	CcSEcCtD
Tetrabenazine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000445	0.00279	CcSEcCtD
Tetrabenazine—Somnolence—Fluorouracil—urinary bladder cancer	0.000444	0.00278	CcSEcCtD
Tetrabenazine—CYP2D6—Biological oxidations—GSTZ1—urinary bladder cancer	0.000442	0.00524	CbGpPWpGaD
Tetrabenazine—Hypotension—Cisplatin—urinary bladder cancer	0.000442	0.00277	CcSEcCtD
Tetrabenazine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000441	0.00276	CcSEcCtD
Tetrabenazine—Fatigue—Gemcitabine—urinary bladder cancer	0.000438	0.00274	CcSEcCtD
Tetrabenazine—Confusional state—Etoposide—urinary bladder cancer	0.000437	0.00274	CcSEcCtD
Tetrabenazine—CYP2D6—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000436	0.00517	CbGpPWpGaD
Tetrabenazine—Constipation—Gemcitabine—urinary bladder cancer	0.000434	0.00272	CcSEcCtD
Tetrabenazine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000434	0.00272	CcSEcCtD
Tetrabenazine—Asthenia—Thiotepa—urinary bladder cancer	0.000433	0.00271	CcSEcCtD
Tetrabenazine—Ataxia—Doxorubicin—urinary bladder cancer	0.00043	0.00269	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—SLC19A1—urinary bladder cancer	0.000429	0.00508	CbGpPWpGaD
Tetrabenazine—Dysphagia—Epirubicin—urinary bladder cancer	0.000427	0.00268	CcSEcCtD
Tetrabenazine—Dysuria—Methotrexate—urinary bladder cancer	0.000427	0.00267	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.000425	0.00266	CcSEcCtD
Tetrabenazine—Dyspnoea—Cisplatin—urinary bladder cancer	0.000422	0.00264	CcSEcCtD
Tetrabenazine—Skin disorder—Etoposide—urinary bladder cancer	0.000421	0.00264	CcSEcCtD
Tetrabenazine—CYP2D6—Biological oxidations—GSTO2—urinary bladder cancer	0.000419	0.00497	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—NAT1—urinary bladder cancer	0.000419	0.00497	CbGpPWpGaD
Tetrabenazine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000419	0.00263	CcSEcCtD
Tetrabenazine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000418	0.00262	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—PRSS3—urinary bladder cancer	0.000418	0.00495	CbGpPWpGaD
Tetrabenazine—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000418	0.00262	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.000418	0.00262	CcSEcCtD
Tetrabenazine—CYP2D6—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000414	0.0049	CbGpPWpGaD
Tetrabenazine—Breast disorder—Doxorubicin—urinary bladder cancer	0.000414	0.00259	CcSEcCtD
Tetrabenazine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000413	0.00259	CcSEcCtD
Tetrabenazine—Decreased appetite—Cisplatin—urinary bladder cancer	0.000411	0.00258	CcSEcCtD
Tetrabenazine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000411	0.00258	CcSEcCtD
Tetrabenazine—Bronchitis—Epirubicin—urinary bladder cancer	0.000411	0.00257	CcSEcCtD
Tetrabenazine—Drowsiness—Methotrexate—urinary bladder cancer	0.000407	0.00255	CcSEcCtD
Tetrabenazine—Depression—Methotrexate—urinary bladder cancer	0.000406	0.00254	CcSEcCtD
Tetrabenazine—Hypotension—Etoposide—urinary bladder cancer	0.000405	0.00254	CcSEcCtD
Tetrabenazine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000401	0.00251	CcSEcCtD
Tetrabenazine—Dysuria—Epirubicin—urinary bladder cancer	0.0004	0.0025	CcSEcCtD
Tetrabenazine—Dizziness—Thiotepa—urinary bladder cancer	0.000399	0.0025	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.000397	0.00249	CcSEcCtD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000397	0.00469	CbGpPWpGaD
Tetrabenazine—Dysphagia—Doxorubicin—urinary bladder cancer	0.000396	0.00248	CcSEcCtD
Tetrabenazine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000395	0.00247	CcSEcCtD
Tetrabenazine—Sweating—Methotrexate—urinary bladder cancer	0.00039	0.00244	CcSEcCtD
Tetrabenazine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00039	0.00244	CcSEcCtD
Tetrabenazine—Dyspnoea—Etoposide—urinary bladder cancer	0.000387	0.00242	CcSEcCtD
Tetrabenazine—Somnolence—Etoposide—urinary bladder cancer	0.000386	0.00241	CcSEcCtD
Tetrabenazine—Vomiting—Thiotepa—urinary bladder cancer	0.000384	0.0024	CcSEcCtD
Tetrabenazine—CYP2D6—Biological oxidations—UGT2B7—urinary bladder cancer	0.000384	0.00454	CbGpPWpGaD
Tetrabenazine—Drowsiness—Epirubicin—urinary bladder cancer	0.000381	0.00239	CcSEcCtD
Tetrabenazine—Bronchitis—Doxorubicin—urinary bladder cancer	0.00038	0.00238	CcSEcCtD
Tetrabenazine—CYP2D6—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000378	0.00448	CbGpPWpGaD
Tetrabenazine—Headache—Thiotepa—urinary bladder cancer	0.000378	0.00237	CcSEcCtD
Tetrabenazine—Decreased appetite—Etoposide—urinary bladder cancer	0.000377	0.00236	CcSEcCtD
Tetrabenazine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000374	0.00234	CcSEcCtD
Tetrabenazine—Fatigue—Etoposide—urinary bladder cancer	0.000374	0.00234	CcSEcCtD
Tetrabenazine—Constipation—Etoposide—urinary bladder cancer	0.000371	0.00232	CcSEcCtD
Tetrabenazine—Dysuria—Doxorubicin—urinary bladder cancer	0.00037	0.00232	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000368	0.0023	CcSEcCtD
Tetrabenazine—Sweating—Epirubicin—urinary bladder cancer	0.000365	0.00229	CcSEcCtD
Tetrabenazine—Asthenia—Gemcitabine—urinary bladder cancer	0.000364	0.00228	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000361	0.00226	CcSEcCtD
Tetrabenazine—Nausea—Thiotepa—urinary bladder cancer	0.000359	0.00225	CcSEcCtD
Tetrabenazine—Urethral disorder—Methotrexate—urinary bladder cancer	0.000358	0.00224	CcSEcCtD
Tetrabenazine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000357	0.00224	CcSEcCtD
Tetrabenazine—Drowsiness—Doxorubicin—urinary bladder cancer	0.000353	0.00221	CcSEcCtD
Tetrabenazine—Bradycardia—Epirubicin—urinary bladder cancer	0.000348	0.00218	CcSEcCtD
Tetrabenazine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000347	0.00218	CcSEcCtD
Tetrabenazine—CYP2D6—Biological oxidations—CYP4B1—urinary bladder cancer	0.000345	0.00409	CbGpPWpGaD
Tetrabenazine—Body temperature increased—Etoposide—urinary bladder cancer	0.000343	0.00215	CcSEcCtD
Tetrabenazine—Eye disorder—Methotrexate—urinary bladder cancer	0.000342	0.00214	CcSEcCtD
Tetrabenazine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000342	0.00214	CcSEcCtD
Tetrabenazine—CYP2D6—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000341	0.00403	CbGpPWpGaD
Tetrabenazine—Asthenia—Cisplatin—urinary bladder cancer	0.00034	0.00213	CcSEcCtD
Tetrabenazine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000339	0.00212	CcSEcCtD
Tetrabenazine—Sweating—Doxorubicin—urinary bladder cancer	0.000338	0.00212	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000338	0.00212	CcSEcCtD
Tetrabenazine—Urethral disorder—Epirubicin—urinary bladder cancer	0.000335	0.0021	CcSEcCtD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000335	0.00397	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—TYMP—urinary bladder cancer	0.000334	0.00396	CbGpPWpGaD
Tetrabenazine—Angiopathy—Methotrexate—urinary bladder cancer	0.000332	0.00208	CcSEcCtD
Tetrabenazine—Dizziness—Fluorouracil—urinary bladder cancer	0.00033	0.00207	CcSEcCtD
Tetrabenazine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000324	0.00203	CcSEcCtD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000323	0.00383	CbGpPWpGaD
Tetrabenazine—Vomiting—Gemcitabine—urinary bladder cancer	0.000323	0.00202	CcSEcCtD
Tetrabenazine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000322	0.00202	CcSEcCtD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000321	0.0038	CbGpPWpGaD
Tetrabenazine—Mental disorder—Methotrexate—urinary bladder cancer	0.00032	0.00201	CcSEcCtD
Tetrabenazine—Eye disorder—Epirubicin—urinary bladder cancer	0.00032	0.002	CcSEcCtD
Tetrabenazine—Headache—Gemcitabine—urinary bladder cancer	0.000318	0.00199	CcSEcCtD
Tetrabenazine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000318	0.00199	CcSEcCtD
Tetrabenazine—Vomiting—Fluorouracil—urinary bladder cancer	0.000317	0.00199	CcSEcCtD
Tetrabenazine—Headache—Fluorouracil—urinary bladder cancer	0.000313	0.00196	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000313	0.00196	CcSEcCtD
Tetrabenazine—Asthenia—Etoposide—urinary bladder cancer	0.000311	0.00195	CcSEcCtD
Tetrabenazine—Angiopathy—Epirubicin—urinary bladder cancer	0.00031	0.00194	CcSEcCtD
Tetrabenazine—Urethral disorder—Doxorubicin—urinary bladder cancer	0.00031	0.00194	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—NAT2—urinary bladder cancer	0.000302	0.00358	CbGpPWpGaD
Tetrabenazine—Nausea—Gemcitabine—urinary bladder cancer	0.000302	0.00189	CcSEcCtD
Tetrabenazine—Vomiting—Cisplatin—urinary bladder cancer	0.000301	0.00188	CcSEcCtD
Tetrabenazine—Mental disorder—Epirubicin—urinary bladder cancer	0.0003	0.00188	CcSEcCtD
Tetrabenazine—Diarrhoea—Etoposide—urinary bladder cancer	0.000297	0.00186	CcSEcCtD
Tetrabenazine—Nausea—Fluorouracil—urinary bladder cancer	0.000297	0.00186	CcSEcCtD
Tetrabenazine—Eye disorder—Doxorubicin—urinary bladder cancer	0.000296	0.00185	CcSEcCtD
Tetrabenazine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000294	0.00184	CcSEcCtD
Tetrabenazine—Tension—Epirubicin—urinary bladder cancer	0.000292	0.00183	CcSEcCtD
Tetrabenazine—Nervousness—Epirubicin—urinary bladder cancer	0.000289	0.00181	CcSEcCtD
Tetrabenazine—Angiopathy—Doxorubicin—urinary bladder cancer	0.000287	0.0018	CcSEcCtD
Tetrabenazine—Dizziness—Etoposide—urinary bladder cancer	0.000287	0.0018	CcSEcCtD
Tetrabenazine—Leukopenia—Methotrexate—urinary bladder cancer	0.000285	0.00178	CcSEcCtD
Tetrabenazine—Nausea—Cisplatin—urinary bladder cancer	0.000281	0.00176	CcSEcCtD
Tetrabenazine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000277	0.00174	CcSEcCtD
Tetrabenazine—Vomiting—Etoposide—urinary bladder cancer	0.000276	0.00173	CcSEcCtD
Tetrabenazine—Agitation—Epirubicin—urinary bladder cancer	0.000274	0.00171	CcSEcCtD
Tetrabenazine—Headache—Etoposide—urinary bladder cancer	0.000272	0.0017	CcSEcCtD
Tetrabenazine—Tension—Doxorubicin—urinary bladder cancer	0.00027	0.00169	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000269	0.00169	CcSEcCtD
Tetrabenazine—Nervousness—Doxorubicin—urinary bladder cancer	0.000268	0.00168	CcSEcCtD
Tetrabenazine—Leukopenia—Epirubicin—urinary bladder cancer	0.000267	0.00167	CcSEcCtD
Tetrabenazine—Confusional state—Methotrexate—urinary bladder cancer	0.000262	0.00164	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—RRM2—urinary bladder cancer	0.000261	0.00309	CbGpPWpGaD
Tetrabenazine—Nausea—Etoposide—urinary bladder cancer	0.000258	0.00161	CcSEcCtD
Tetrabenazine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000255	0.0016	CcSEcCtD
Tetrabenazine—Agitation—Doxorubicin—urinary bladder cancer	0.000253	0.00159	CcSEcCtD
Tetrabenazine—Anxiety—Epirubicin—urinary bladder cancer	0.000253	0.00158	CcSEcCtD
Tetrabenazine—Skin disorder—Methotrexate—urinary bladder cancer	0.000252	0.00158	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000252	0.00158	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000251	0.00157	CcSEcCtD
Tetrabenazine—Dry mouth—Epirubicin—urinary bladder cancer	0.000248	0.00155	CcSEcCtD
Tetrabenazine—Leukopenia—Doxorubicin—urinary bladder cancer	0.000247	0.00154	CcSEcCtD
Tetrabenazine—Confusional state—Epirubicin—urinary bladder cancer	0.000245	0.00153	CcSEcCtD
Tetrabenazine—Hypotension—Methotrexate—urinary bladder cancer	0.000243	0.00152	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—ENO2—urinary bladder cancer	0.000242	0.00286	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—HPGDS—urinary bladder cancer	0.000242	0.00286	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.00024	0.00284	CbGpPWpGaD
Tetrabenazine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000238	0.00149	CcSEcCtD
Tetrabenazine—Skin disorder—Epirubicin—urinary bladder cancer	0.000236	0.00148	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000235	0.00147	CcSEcCtD
Tetrabenazine—Insomnia—Methotrexate—urinary bladder cancer	0.000235	0.00147	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—GSTT1—urinary bladder cancer	0.000234	0.00277	CbGpPWpGaD
Tetrabenazine—Anxiety—Doxorubicin—urinary bladder cancer	0.000234	0.00146	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000233	0.00146	CcSEcCtD
Tetrabenazine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000232	0.00145	CcSEcCtD
Tetrabenazine—Somnolence—Methotrexate—urinary bladder cancer	0.000231	0.00145	CcSEcCtD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000231	0.00273	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—NAT2—urinary bladder cancer	0.00023	0.00272	CbGpPWpGaD
Tetrabenazine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000229	0.00144	CcSEcCtD
Tetrabenazine—Hypotension—Epirubicin—urinary bladder cancer	0.000227	0.00142	CcSEcCtD
Tetrabenazine—Confusional state—Doxorubicin—urinary bladder cancer	0.000227	0.00142	CcSEcCtD
Tetrabenazine—CYP2D6—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000227	0.00268	CbGpPWpGaD
Tetrabenazine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000226	0.00141	CcSEcCtD
Tetrabenazine—Fatigue—Methotrexate—urinary bladder cancer	0.000224	0.0014	CcSEcCtD
Tetrabenazine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000221	0.00138	CcSEcCtD
Tetrabenazine—Insomnia—Epirubicin—urinary bladder cancer	0.00022	0.00138	CcSEcCtD
Tetrabenazine—Skin disorder—Doxorubicin—urinary bladder cancer	0.000218	0.00137	CcSEcCtD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000218	0.00258	CbGpPWpGaD
Tetrabenazine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000217	0.00136	CcSEcCtD
Tetrabenazine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000217	0.00136	CcSEcCtD
Tetrabenazine—Somnolence—Epirubicin—urinary bladder cancer	0.000216	0.00135	CcSEcCtD
Tetrabenazine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000214	0.00134	CcSEcCtD
Tetrabenazine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000211	0.00132	CcSEcCtD
Tetrabenazine—Hypotension—Doxorubicin—urinary bladder cancer	0.00021	0.00132	CcSEcCtD
Tetrabenazine—Fatigue—Epirubicin—urinary bladder cancer	0.00021	0.00131	CcSEcCtD
Tetrabenazine—Constipation—Epirubicin—urinary bladder cancer	0.000208	0.0013	CcSEcCtD
Tetrabenazine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000205	0.00129	CcSEcCtD
Tetrabenazine—Insomnia—Doxorubicin—urinary bladder cancer	0.000203	0.00127	CcSEcCtD
Tetrabenazine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000201	0.00126	CcSEcCtD
Tetrabenazine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.0002	0.00125	CcSEcCtD
Tetrabenazine—Somnolence—Doxorubicin—urinary bladder cancer	0.0002	0.00125	CcSEcCtD
Tetrabenazine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000196	0.00122	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—NQO1—urinary bladder cancer	0.000195	0.00231	CbGpPWpGaD
Tetrabenazine—Fatigue—Doxorubicin—urinary bladder cancer	0.000194	0.00121	CcSEcCtD
Tetrabenazine—Constipation—Doxorubicin—urinary bladder cancer	0.000192	0.0012	CcSEcCtD
Tetrabenazine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000192	0.0012	CcSEcCtD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000189	0.00224	CbGpPWpGaD
Tetrabenazine—Asthenia—Methotrexate—urinary bladder cancer	0.000186	0.00117	CcSEcCtD
Tetrabenazine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000185	0.00116	CcSEcCtD
Tetrabenazine—CYP2D6—Biological oxidations—HPGDS—urinary bladder cancer	0.000184	0.00217	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—GSTT1—urinary bladder cancer	0.000178	0.00211	CbGpPWpGaD
Tetrabenazine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000178	0.00111	CcSEcCtD
Tetrabenazine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000178	0.00111	CcSEcCtD
Tetrabenazine—Asthenia—Epirubicin—urinary bladder cancer	0.000174	0.00109	CcSEcCtD
Tetrabenazine—DRD2—Circadian rythm related genes—TYMS—urinary bladder cancer	0.000174	0.00206	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—NCOR1—urinary bladder cancer	0.000172	0.00203	CbGpPWpGaD
Tetrabenazine—Dizziness—Methotrexate—urinary bladder cancer	0.000172	0.00108	CcSEcCtD
Tetrabenazine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000166	0.00104	CcSEcCtD
Tetrabenazine—Vomiting—Methotrexate—urinary bladder cancer	0.000165	0.00103	CcSEcCtD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000165	0.00195	CbGpPWpGaD
Tetrabenazine—Headache—Methotrexate—urinary bladder cancer	0.000163	0.00102	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—GSTP1—urinary bladder cancer	0.000162	0.00192	CbGpPWpGaD
Tetrabenazine—Asthenia—Doxorubicin—urinary bladder cancer	0.000161	0.00101	CcSEcCtD
Tetrabenazine—Dizziness—Epirubicin—urinary bladder cancer	0.000161	0.00101	CcSEcCtD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000157	0.00186	CbGpPWpGaD
Tetrabenazine—Vomiting—Epirubicin—urinary bladder cancer	0.000155	0.000968	CcSEcCtD
Tetrabenazine—Nausea—Methotrexate—urinary bladder cancer	0.000154	0.000966	CcSEcCtD
Tetrabenazine—DRD2—Circadian rythm related genes—FAS—urinary bladder cancer	0.000154	0.00182	CbGpPWpGaD
Tetrabenazine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000154	0.000964	CcSEcCtD
Tetrabenazine—Headache—Epirubicin—urinary bladder cancer	0.000152	0.000954	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—TYMS—urinary bladder cancer	0.000151	0.00179	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—NCOR1—urinary bladder cancer	0.000149	0.00177	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—GSTM1—urinary bladder cancer	0.000149	0.00177	CbGpPWpGaD
Tetrabenazine—Dizziness—Doxorubicin—urinary bladder cancer	0.000149	0.000931	CcSEcCtD
Tetrabenazine—Nausea—Epirubicin—urinary bladder cancer	0.000144	0.000904	CcSEcCtD
Tetrabenazine—Vomiting—Doxorubicin—urinary bladder cancer	0.000143	0.000896	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—GPX1—urinary bladder cancer	0.000143	0.00169	CbGpPWpGaD
Tetrabenazine—Headache—Doxorubicin—urinary bladder cancer	0.000141	0.000882	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—ERCC2—urinary bladder cancer	0.00014	0.00166	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—CDK4—urinary bladder cancer	0.000135	0.0016	CbGpPWpGaD
Tetrabenazine—Nausea—Doxorubicin—urinary bladder cancer	0.000134	0.000837	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—MTHFR—urinary bladder cancer	0.000132	0.00156	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	0.000124	0.00146	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—PPARG—urinary bladder cancer	0.000123	0.00146	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000122	0.00144	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000116	0.00137	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	0.000113	0.00134	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000112	0.00133	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PPARG—urinary bladder cancer	0.000107	0.00127	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—CREBBP—urinary bladder cancer	0.000103	0.00122	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000102	0.00121	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—HRAS—urinary bladder cancer	8.86e-05	0.00105	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—PTEN—urinary bladder cancer	8.45e-05	0.001	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PTGS2—urinary bladder cancer	8.42e-05	0.000996	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—CXCL8—urinary bladder cancer	8.29e-05	0.000981	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—EP300—urinary bladder cancer	8.05e-05	0.000953	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	7.57e-05	0.000896	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HDAC4—urinary bladder cancer	7.43e-05	0.00088	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PTEN—urinary bladder cancer	7.34e-05	0.000869	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	7.17e-05	0.000849	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NAT1—urinary bladder cancer	7.17e-05	0.000849	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—EP300—urinary bladder cancer	7e-05	0.000829	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	6.59e-05	0.00078	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	6.56e-05	0.000777	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GLI1—urinary bladder cancer	6.23e-05	0.000737	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	5.91e-05	0.000699	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—TP53—urinary bladder cancer	5.76e-05	0.000682	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	5.58e-05	0.00066	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	5.44e-05	0.000643	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—CXCL8—urinary bladder cancer	5.02e-05	0.000594	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	4.35e-05	0.000514	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RBX1—urinary bladder cancer	4.27e-05	0.000505	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TSC1—urinary bladder cancer	4.01e-05	0.000475	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	3.93e-05	0.000465	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—JAG1—urinary bladder cancer	3.82e-05	0.000452	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	3.39e-05	0.000402	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—RHOA—urinary bladder cancer	3.23e-05	0.000382	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	3.14e-05	0.000372	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	3.14e-05	0.000372	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—S100B—urinary bladder cancer	3.09e-05	0.000366	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	3.05e-05	0.000361	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—RHOA—urinary bladder cancer	2.93e-05	0.000347	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.84e-05	0.000336	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NCOR1—urinary bladder cancer	2.78e-05	0.000329	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—IL2—urinary bladder cancer	2.71e-05	0.000321	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CXCL8—urinary bladder cancer	2.58e-05	0.000305	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	2.53e-05	0.0003	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—IL2—urinary bladder cancer	2.46e-05	0.000291	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TERT—urinary bladder cancer	2.45e-05	0.00029	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FGFR3—urinary bladder cancer	2.25e-05	0.000266	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ESR1—urinary bladder cancer	2.19e-05	0.000259	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	2.11e-05	0.00025	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.96e-05	0.000232	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.94e-05	0.00023	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.94e-05	0.00023	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CREBBP—urinary bladder cancer	1.92e-05	0.000227	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IGF1—urinary bladder cancer	1.89e-05	0.000224	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—EGFR—urinary bladder cancer	1.88e-05	0.000223	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.86e-05	0.00022	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.82e-05	0.000216	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—KRAS—urinary bladder cancer	1.78e-05	0.00021	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RHOA—urinary bladder cancer	1.73e-05	0.000205	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.72e-05	0.000203	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ERBB2—urinary bladder cancer	1.6e-05	0.00019	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CXCL8—urinary bladder cancer	1.52e-05	0.00018	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—HRAS—urinary bladder cancer	1.51e-05	0.000179	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IL2—urinary bladder cancer	1.45e-05	0.000172	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CCND1—urinary bladder cancer	1.42e-05	0.000168	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.39e-05	0.000165	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MMP9—urinary bladder cancer	1.38e-05	0.000163	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CDKN1A—urinary bladder cancer	1.37e-05	0.000162	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PTEN—urinary bladder cancer	1.37e-05	0.000162	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.34e-05	0.000158	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EP300—urinary bladder cancer	1.3e-05	0.000154	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SRC—urinary bladder cancer	1.27e-05	0.00015	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MYC—urinary bladder cancer	1.14e-05	0.000135	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EGFR—urinary bladder cancer	1.11e-05	0.000132	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.09e-05	0.00013	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—KRAS—urinary bladder cancer	1.05e-05	0.000124	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	9.54e-06	0.000113	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TP53—urinary bladder cancer	9.34e-06	0.000111	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—EP300—urinary bladder cancer	9.1e-06	0.000108	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HRAS—urinary bladder cancer	8.93e-06	0.000106	CbGpPWpGaD
